Press release
Liquid Embolic System Market Outlook 2025-2034: Neurovascular Advances and Rising Brain Aneurysm Cases Drive Market Growth
Liquid Embolic System Market
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/58985
Key Market Drivers:
• Rising global burden of brain aneurysms and AVMs
• Increasing adoption of image-guided and catheter-based neurovascular surgeries
• High efficacy and lower recurrence rates compared to traditional embolic coils
• Expanding availability of hybrid operating rooms and neuroendovascular expertise
Key Market Challenges:
• High cost of liquid embolic products and procedure infrastructure
• Risk of non-target embolization and catheter entrapment
• Need for advanced imaging and highly skilled interventional radiologists
Market Segmentation
By Product:
• Non-Adhesive Liquid Embolic Agents
• Adhesive Liquid Embolic Agents
By Application:
• Brain Arteriovenous Malformations (AVMs)
• Aneurysms
• Tumor Embolization
• Gastrointestinal Bleeding
• Others (Spinal AVMs, Trauma)
By End User:
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)
• Academic and Research Institutes
Summary:
Non-adhesive liquid embolic agents (e.g., Onyx, Squid) are widely preferred due to better handling, lower toxicity, and minimal adherence to catheter surfaces. Brain AVMs and aneurysms remain the largest application segments, while tumor embolization is gaining momentum in oncology settings. Hospitals account for the majority of demand due to access to surgical suites, advanced imaging, and trained specialists.
Get Your Exclusive Offer with up to 10% Discount:
https://exactitudeconsultancy.com/purchase/?currency=USD&type=single_user_license&report_id=58985
Regional Analysis
North America
• Largest market share due to the high prevalence of cerebrovascular disorders
• U.S. leads in both procedural volume and product innovation
• Favorable reimbursement and robust neurointervention ecosystem
Europe
• Germany, France, and the UK dominate the regional market
• Rapid growth in interventional neuroradiology departments
• CE approvals for advanced non-adhesive embolic agents (e.g., Squid, PHIL)
Asia-Pacific
• Fastest-growing region due to expanding healthcare access and medical tourism
• Rising awareness of stroke and AVM treatment options in China, India, and Japan
• Investments in infrastructure and training for neurointerventionists
Middle East & Africa
• Increasing adoption in UAE, Saudi Arabia, and South Africa for trauma and tumor embolization
• Public-private hospital collaborations improving accessibility to high-end embolization techniques
Latin America
• Brazil and Mexico emerging as high-potential markets with increasing stroke care networks
• Growth in private sector investments in diagnostic imaging and neurovascular suites
Regional Summary:
While North America and Europe lead in technology adoption and procedural infrastructure, Asia-Pacific is poised for exponential growth thanks to rising stroke burden, supportive government initiatives, and infrastructure modernization.
Market Dynamics
Growth Drivers:
• Global Stroke Burden: WHO estimates over 12 million strokes annually, many requiring endovascular treatment options.
• Clinical Superiority Over Coils: Liquid embolics provide deeper vessel penetration and higher occlusion rates, especially in complex AVMs.
• Hybrid Operating Rooms and Interventional Suites: Surge in neurosurgical centers with integrated DSA, MRI, and cath lab systems.
• Tumor Embolization Expansion: Liquid embolics are increasingly used pre-operatively to reduce tumor blood supply in oncology.
Key Challenges:
• Cost Sensitivity in Emerging Markets: High price of products like Onyx and PHIL limits access in budget-constrained healthcare systems.
• Operator Dependency: Success and safety are highly reliant on the experience and precision of the interventionist.
• Side Effects: Non-target embolization, vessel rupture, and catheter retention are key clinical risks.
Emerging Trends:
• Next-Gen Non-Adhesive Agents: Materials with improved radiopacity, lower viscosity, and longer working time
• Drug-Loaded Embolic Systems: Embolic agents combined with chemotherapy or radioisotopes for dual-action in cancer treatment
• AI-Driven Embolization Planning: Tools that simulate vascular flow and optimize catheter navigation
• Personalized Embolic Delivery Kits: Pre-loaded microcatheter systems for streamlined surgical workflow
Explore Full Report here:
https://exactitudeconsultancy.com/reports/58985/global-liquid-embolic-system-market
Competitive Landscape
Major Players:
• Medtronic Plc
• Johnson & Johnson (CERENOVUS)
• Terumo Corporation
• BALT Group
• Merit Medical Systems, Inc.
• Stryker Corporation
• Penumbra Inc.
• MicroVention Inc. (a Terumo company)
• Emboflu Inc.
• Guerbet Group
• Shape Memory Medical
• Asahi Intecc Co., Ltd.
• Kaneka Corporation
• Rapid Medical
• Johnson Matthey
• MIVI Neuroscience
• Evasc Neurovascular
• Medico's Hirata
• Innovative Targeting Solutions
• Nordson Corporation
Competitive Summary:
The market is moderately consolidated, with leading players like Medtronic, Stryker, BALT, and J&J's CERENOVUS dominating product portfolios. Product differentiation focuses on radiopacity, catheter compatibility, embolization depth, and controlled injection.
Key strategies include:
• Launch of next-gen agents like Squid, PHIL, and Precipitating Hydrophobic Injectable Liquid
• Partnerships with neurosurgery and oncology centers for clinical trials and procedural training
• Expansion into Asia and Latin America through distributor alliances and regulatory approvals
Conclusion:
A Vascular Game-Changer in Neuro and Oncology Care
The global Liquid Embolic System market is evolving rapidly, offering unparalleled precision in treating complex vascular lesions such as AVMs, aneurysms, and tumors. As demand for minimally invasive, image-guided procedures accelerates, so too will the adoption of advanced embolization agents.
With a projected CAGR of 6.6% through 2034, and strong demand from both developed and emerging regions, the market offers compelling growth opportunities for manufacturers, hospitals, and investors focused on neurovascular care innovation.
This report is also available in the following languages : Japanese (液体塞栓システム), Korean (액체 색전 시스템), Chinese (液体栓塞系统), French (Système d'embolie liquide), German (Flüssigemboliesystem), and Italian (Sistema embolico liquido), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/reports/58985/global-liquid-embolic-system-market#request-a-sample
Our More Report:
Viscosupplementation Injection
https://exactitudeconsultancy.com/reports/64080/global-viscosupplementation-injection-market
Digital Mammography Machine
https://exactitudeconsultancy.com/reports/64082/global-digital-mammography-machine-market
Dietary Modified Starch
https://exactitudeconsultancy.com/reports/64084/global-dietary-modified-starch-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liquid Embolic System Market Outlook 2025-2034: Neurovascular Advances and Rising Brain Aneurysm Cases Drive Market Growth here
News-ID: 4118827 • Views: …
More Releases from Exactitiude Consultancy
Non-Muscle Invasive Bladder Cancer Market Industry Analysis by Size, Share, Grow …
Introduction
The Non-Muscle Invasive Bladder Cancer (NMIBC) market is poised for significant growth as advancements in intravesical therapies, immuno-oncology drugs, and molecular diagnostics improve patient outcomes. NMIBC, which accounts for about 70-75% of all newly diagnosed bladder cancer cases, is characterized by high recurrence rates but relatively low mortality compared to muscle-invasive forms. The rising global prevalence, particularly among aging populations, is prompting greater investment in early diagnosis, novel drug delivery…
NK Cell Therapy Market Size And Global Industry Forecast 2034
NK Cell Therapy Market Outlook 2024-2034: Immuno-Oncology Innovation and Off-the-Shelf Therapies Set the Stage for Rapid Growth
Introduction
The Natural Killer (NK) Cell Therapy market is one of the most dynamic segments in immuno-oncology, driven by breakthroughs in cell engineering, off-the-shelf allogeneic therapies, and combination regimens with checkpoint inhibitors. NK cells, part of the innate immune system, have demonstrated strong potential in targeting and destroying cancer cells without prior sensitization, making them…
Neuroendocrine Prostate Cancer Market Size, Share and Growth Report, 2034
Introduction
The Neuroendocrine Prostate Cancer (NEPC) market is emerging as a key focus area in oncology due to its aggressive nature, poor prognosis, and increasing recognition as a distinct clinical entity. NEPC can develop de novo or as a treatment-emergent form of advanced prostate cancer following androgen deprivation therapy (ADT) resistance. While rare, NEPC is challenging to treat, requiring a combination of chemotherapy, targeted agents, and investigational therapies. Rising awareness, advancements…
Metastatic Colorectal Cancer Market Size And Global Industry Forecast 2034
Introduction
The Metastatic Colorectal Cancer (mCRC) market is entering a transformative phase as precision medicine, biomarker-driven treatment strategies, and immunotherapy reshape patient care. Increasing adoption of EGFR inhibitors, VEGF inhibitors, immune checkpoint inhibitors, and combination regimens is improving survival rates, while advancements in molecular diagnostics are enabling more tailored treatment approaches. Over the next decade, continuous R&D efforts and expanded access to innovative therapies are expected to drive market growth.
Download Full…
More Releases for Liquid
Vitamins: The Liquid Goldmine in the Booming Liquid Dietary Supplements Market
The liquid dietary supplements market is experiencing a surge in popularity, driven by consumers seeking convenient and effective ways to boost their health and wellness. Among the diverse offerings, the vitamins segment stands out as a high-opportunity area, catering to a wide range of health needs and preferences.
Market Dynamics and Growth Drivers
Liquid vitamins offer a compelling alternative to traditional pills and capsules, providing faster absorption, easier consumption, and customizable dosages.…
Thermoelectric Assemblies Market, By Type (Air to Air, Direct to Air, Liquid to …
The thermoelectric assemblies market is expected to witness market growth at a rate of 8.25% in the forecast period of 2021 to 2028. Data Bridge Market Research report on thermoelectric assemblies market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in the application of thermoelectric assemblies in the food and beverage industry…
Southeast Asia Liquid Gases Market : Growing with a CAGR of 7.1%, By Type (Liqui …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Southeast Asia Liquid Gases Market growing with a CAGR of 7.1%, By Type (Liquid …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Southeast Asia liquid gases market growing with a CAGR of 7.1%, Size, Share, Tre …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Dual Chamber Prefilled Syringes Market 2021 by Product (Liquid/Powder, Liquid/Li …
The Dual Chamber Prefilled Syringes Market report examines the market size by vital countries/regions, product type, application, historical data, and estimate to forecast. It helps to understand the structure of the Dual Chamber Prefilled Syringes Market by recognizing its different sub-segments. Furthermore, the report focuses on key market players to determine, describe and analyze the value, market share, market competition landscape, SWOT analysis, and development plans in the next few…
